Clinical Trial Update: Coronary Drug Project [Phase 3]

View source ↗

Summary

An NHLBI-sponsored Phase 3 Coronary Drug Project trial has completed, with reported cardiovascular outcome results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Coronary Artery Disease
• Heart Disease
• Myocardial Infarction
• Myocardial Ischemia

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Cardiovascular Diseases, Coronary Disease | Phase 3 | Status: COMPLETED